Table 5 Assessment of platelet activity and reactivity in patients with and without vascular risk factors:
Patient without risk factors | Patients with risk factors | Test value | p-value | |||
|---|---|---|---|---|---|---|
Platelet activation (in vivo) | Baseline CD62P % | Mean ± SD | 30.5 ± 12.4 | 34.2 ± 13.7 | T = 1.1 | 0.02* |
Baseline CD62P MFI | Mean ± SD | 75.6 ± 30.7 | 84.7 ± 41.5 | T = 1 | 0.3 | |
Platelet reactivity (in vitro) | ADP induced CD62P% | Mean ± SD | 72.8 ± 16.3 | 73.1 ± 12.2 | T = − 0.07 | 0.9 |
ADP induced CD62P MFI | Mean ± SD | 212.8 ± 80.3 | 218.7 ± 67.7 | T = − 0.2 | 0.7 | |